← All companies

CBDL

CBD Life Sciences Inc.

CBDL OTC Medicinal Chemicals & Botanical Products EDGAR ↗

$0.00

+0.00 +17.65%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.00 – $0.00

Recent SEC filings

40 most recent

Other filings

QUALIF Jun 8, 2026 1-A May 15, 2026 253G2 FORM 253G2 May 19, 2025 QUALIF Mar 19, 2025 CORRESP Mar 18, 2025 CORRESP Mar 17, 2025 1-A POS Mar 17, 2025 UPLOAD Mar 17, 2025 1-A POS Mar 6, 2025 1-U Item 9.1 Jan 22, 2025 253G2 Sep 19, 2024 QUALIF Sep 17, 2024 CORRESP Sep 16, 2024 CORRESP Sep 16, 2024 CORRESP Sep 6, 2024 1-A POS Sep 6, 2024 UPLOAD Sep 5, 2024 1-A POS Aug 19, 2024 253G1 Jun 24, 2024 QUALIF Jun 21, 2024 CORRESP Jun 18, 2024 1-A/A Jun 18, 2024 CORRESP Jun 17, 2024 UPLOAD Jun 17, 2024 CORRESP Jun 5, 2024 1-A/A Jun 5, 2024 UPLOAD May 29, 2024 1-A May 2, 2024 1-Z May 1, 2024 1-U Item 7; Item 9.1 Jan 8, 2024 253G1 FORM 253G1 Aug 29, 2022 QUALIF Aug 26, 2022 CORRESP Aug 24, 2022 UPLOAD Aug 22, 2022 1-A Aug 18, 2022 1-Z Aug 18, 2022 253G2 FORM 253(G)(2) Jan 25, 2022 253G2 PROSPECTUS SUPPLEMENT Sep 1, 2021 253G2 PROSPECTUS SUPPLEMENT Jul 20, 2021 QUALIF Jul 13, 2021